Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study by Suenaga M, Mizunuma N, Matsusaka S, Shinozaki E, Ozaka M, Ogura M, Yamaguchi T

Get full text

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer by Suenaga M, Mizunuma N, Matsusaka S, Shinozaki E, Ozaka M, Ogura M, Chin K, Yamaguchi T

Get full text

On the drastic reduction of organic structure directing agent in the steam-assisted crystallization of zeolite with hierarchical porosity by Rilyanti, M., Mukti, R. R., Kadja, G. T. M., Ogura, M., Nur, H., Ng, E. P., Ismunandar, Ismunandar

Treatment features of systemic chemotherapy in young adults with unresectable advanced or recurrent gastric cancer by Nakayama I, Chin K, Takahari D, Ogura M, Ichimura T, Wakatsuki T, Osumi H, Ota Y, Suzuki T, Suenaga M, Shinozaki E, Yamaguchi K

Get full text

Safety and efficacy of amrubicin monotherapy in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract: a single cancer center retrospe... by Kitagawa Y, Osumi H, Shinozaki E, Ota Y, Nakayama I, Suzuki T, Wakatsuki T, Ichimura T, Ogura M, Ooki A, Takahari D, Suenaga M, Chin K, Yamaguchi K

Get full text

Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion. by Gheni, G, Ogura, M, Iwasaki, M, Yokoi, N, Minami, K, Nakayama, Y, Harada, K, Hastoy, B, Wu, X, Takahashi, H, Kimura, K, Matsubara, T, Hoshikawa, R, Hatano, N, Sugawara, K, Shibasaki, T, Inagaki, N, Bamba, T, Mizoguchi, A, Fukusaki, E, Rorsman, P, Seino, S